Diagnosis and management of anal cancer

Current Gastroenterology Reports

Volumn 10, Issue 5, 2008, Pages 502-506

  Gervaz, Pascal ^a   Buchs, Nicolas ^a   Morel, Philippe ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CISPLATIN; FLUOROURACIL; IMIQUIMOD; MITOMYCIN C; PROTEIN E7; SGN 00101; UNCLASSIFIED DRUG; WART VIRUS VACCINE;

ANUS CANCER; BLOOD TOXICITY; CANCER SCREENING; CLINICAL TRIAL; DRUG TOLERABILITY; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENCE; INTENSITY MODULATED RADIATION THERAPY; MONOTHERAPY; PATIENT CARE PLANNING; PRECANCER; REVIEW; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TREATMENT OUTCOME; ANUS TUMOR;

ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; HUMANS;

EID: 58149357407     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-008-0092-x     Document Type: Review

References (45)

1. Jemal A, Siegel R, Ward E, et al.: Cancer statistics 2008. CA Cancer J Clin 2008, 58: 71-96.
2. Brewster DH, Bhatti LA: Increasing incidence of squamous cell carcinoma of the anus in Scotland, 1975-2002. Br J Cancer 2006, 95: 87-90.
3. Frisch M, Glimelius B, van den Brule AJC, et al.: Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997, 337: 1350-1358.
4. Gervaz P, Hirschel B, Morel P: Molecular biology of squamous cell carcinoma of the anus. Br J Surg 2006, 93: 531-538.
5. Aigner F, Boeckle E, Albright J, et al.: Malignancies of the colorectum and anus in solid organ recipients. Transpl Int 2007, 20: 497-504.
6. Konstantinopoulos PA, Schlecht HP, Bryan B, et al.: HIV-associated anal squamous cell cancer: An otherwise preventable disease. J Clin Oncol 2006, 24: 4516-4517.
7. Ryan DP, Compton C, Mayer RJ: Carcinoma of the anal canal. N Engl J Med 2000, 342: 792-800.
8. Abbasakoor F, Boulos PB: Anal intraepithelial neoplasia. Br J Surg 2005, 92: 277-290.
9. Piketty C, Darragh T, Heard I, et al.: High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy. Sex Transm Dis 2004, 31: 96-99.
10. Abramowitz L, Benabderrahmane D, Ravaud P, et al.: Anal squamous intraepithelial lesions and condyloma in HIV-infected heterosexual men, homosexual men and women: Prevalence and associated factors. AIDS 2007, 21: 1457-1465.
11. Tramujas da Costa e Silva I, de Lima Ferreira LC, Santos Gimenez F, et al.: High-resolution anoscopy in the diagnosis of anal cancer precursor lesions in renal graft recipients. Ann Surg Oncol 2008, 15: 1470-1475.
12. Pineda CE, Berry JM, Jay N, et al.: High resolution anoscopy in the planned staged treatment of anal squamous intraepithelial lesions in HIV-negative patients. J Gastrointest Surg 2007, 11: 1410-1415.
13. Jay N, Berry JM, Hogeboom CJ, et al.: Colposcopic appearance of anal squamous intraepithelial lesions: Relationship to histopathology. Dis Colon Rectum 1997, 40: 919-928.
14. Fox PA, Seet JE, Stebbing J, et al.: The value of anal cytology and human papillomavirus typing in the detection of anal intraepithelial neoplasia: A review of cases from an anoscopy clinic. Sex Transm Infect 2005, 81: 142-146.
15. Chiao EY, Giordano TP, Palefsky JM: Screening HIV-infected individuals for anal cancer precursor lesions: A systematic review. Clin Infect Dis 2006, 43: 223-233.
16. Scholefield JH, Castle MT, Watson NF: Malignant transformation of high-grade anal intraepithelial neoplasia. Br J Surg 2005, 92: 1133-1136.
17. Devaraj B, Cosman BC: Expectant management of anal squamous dysplasia in patients with HIV. Dis Colon Rectum 2006, 49: 36-40.
18. Goldstone SE, KAwalek AZ, Huyett JW: Infrared coagulator: a useful tool for treating anal squamous intraepithelial lesions. Dis Colon Rectum 2005, 48: 1042-1054.
19. Kreuter A, Potthoff A, Brockmeyer NH, et al.: Imiquimod leads to a decrease of human papillomavirus DNA and to a sustained clearance of anal intraepithelial neoplasia in HIV-infected men. J Invest Dermatol 2008, 128: 2078-2083.
20. Pineda CE, Berry JM, Jay N, et al.: High-resolution anoscopy targeted surgical destruction of anal high-grade squamous intraepithelial lesions: A ten-year experience. Dis Colon Rectum 2008, 51: 829-835.
21. Joura EA, Leodolter S, Hernandez-Avila M, et al.: Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16 and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: A combined analysis of three randomised clinical trials. Lancet 2007, 369: 1693-1702.
22. Palefsky JM, Berry JM, Jay N, et al.: A trial of SGN-00101 (HspE7) to treat high-grade anal intraepithelial neoplasia in HIV-positive individuals. AIDS 2006, 20: 1151-1155.
23. Nigro ND, Vaitkevicius VK, Buroker T, et al.: Combined therapy for cancer of the anal canal. Dis Colon Rectum 1981, 24: 73-75.
24. Bartelink H, Roelofsen F, Eschwege F, et al.: Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997, 15: 2040-2049.
25. Northover JMA, UKCCCR Anal Cancer Trial Working Party: Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet 1996, 348: 1049-1054.
26. Flam M, John M, Pajak TF, et al.: Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study. J Clin Oncol 1996, 14: 2527-2539.
27. Roohipour R, Patil S, Goodman KA, et al.: Squamous-cell carcinoma of the anal canal: Predictors of treatment outcome. Dis Colon Rectum 2008, 51: 147-153.
28. Das P, Bhatia S, Eng C, et al.: Predictors and patterns of recurrence after definitive chemoradiation for anal cancer. Int J Radiat Oncol Biol Phys 2007, 68: 794-800.
29. Gervaz P, Lavertu S, Kazemba B, et al.: Sphincter-preserving radiation therapy for rectal cancer: A simulation study using three-dimensional computerized technology. Colorectal Dis 2006, 8: 570-574.
30. Salama JK, Mell LK, Schomas DA, et al.: Concurrent chemotherapy and intensity-modulated radiation therapy for anal cancer patients: A multicenter experience. J Clin Oncol 2007, 25: 4581-4586.
31. Vuong T, Kopek N, Ducruet T, et al.: Conformal therapy improves the therapeutic index of patients with anal canal cancer treated with combined chemotherapy and external beam radiotherapy. Int J Radiat Oncol Biol Phys 2007, 67: 1394-1400.
32. Hung A, Crane C, Delclos M, et al.: Cisplatin-based combined modality therapy for anal carcinoma: A wider therapeutic index. Cancer 2003, 97: 1195-1202.
33. Ajani JA, Winter KA, Gunderson LL, et al.: Fluorouracil, mitomycin and radiotherapy vs. fluorouracil, cisplatin and radiotherapy for carcinoma of the anal canal. JAMA 2008, 299: 1914-1921.
34. Crehange G, Bosset M, Lorchel F, et al.: Combining cisplatin and mitomycin with radiotherapy in anal carcinoma. Dis Colon Rectum 2007, 50: 43-49.
35. Schiller DE, Cummings BJ, Rai S, et al.: Outcomes of salvage surgery for squamous cell carcinoma of the anal canal. Ann Surg Oncol 2007, 14: 2780-2789.
36. Papaconstantinou HT, Bullard KM, Rothenberger DA, et al.: Salvage abdominoperineal resection after failed Nigro protocol: Modest success, major morbidity. Colorectal Dis 2006, 8: 124-129.
37. Stewart D, Yan Y, Kodner IJ, et al.: Salvage surgery after failed chemoradiation for anal canal cancer: Should the paradigm be changed for high-risk tumors? J Gastrointest Surg 2007, 11: 1744-1751.
38. Cleator S, Fife K, Nelson M, et al.: Treatment of HIV-associated invasive anal cancer with combined chemoradiation. Eur J Cancer 2000, 36: 754-758.
39. Kim JH, Sarani B, Orkin BA, et al.: HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients. Dis Colon Rectum 2001, 44: 1496-1502.
40. Clifford GM, Polesel J, Rickenbach M, et al.: Cancer risk in the Swiss HIV cohort study: Association with immunodeficiency, smoking and highly active antiretroviral therapy. J Natl Cancer Inst 2005, 97: 425-432.
41. Gervaz P, Hahnloser D, Wolff BG, et al.: Molecular biology of squamous cell carcinoma of the anus: A comparison of HIV-positive and HIV-negative patients. J Gastrointest Surg 2004, 8: 1024-1031.
42. Oehler-Jänne C, Seifert B, Lütolf UM, Ciernik IF: Local tumor control and toxicity in HIV-associated anal carcinoma treated with radiotherapy in the era of antiretroviral therapy. Radiat Oncol 2006, 1: 29.
43. Wexler A, Berson AM, Goldstone SE, et al.: Invasive anal squamous-cell carcinoma in the HIV-positive patient: Outcome in the era of highly active antiretroviral therapy. Dis Colon Rectum 2008, 51: 73-81.
44. Blazy A, Hennequin C, Gornet JM, et al.: Anal carcinomas in HIV-positive patients: High-dose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy. Dis Colon Rectum 2005, 48: 1176-1181.
45. Chiao EY, Giordano TP, Richardson P, et al.: Human immunodeficiency virus-associated squamous cell cancer of the anus: Epidemiology and outcomes in the highly active antiretroviral therapy era. J Clin Oncol 2008, 26: 474-479.